CDKN2A and familial pancreatic carcinoma: Genetic studies have identified structural mutations in pancreatic cancers; the alterations include the activation of K-Ras proto-oncogene as well as inactivation of tumor suppressor genes such as TP53 or INK4a locus [47–49].